phase 2_initiation
saveChongqing Cancer Hospital — ondansetron (Phase II Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Ovarian Cancer
Data sources
globaldata
Found something off?
drug timeline · 8
- approvalONDANSETRON — FDA approvalNov 24, 2025 · 319d ago
- approvalONDANSETRON — FDA approvalNov 17, 2025 · 326d ago
- approvalONDANSETRON — FDA approvalMay 31, 2024 · 861d ago
- approvalONDANSETRON — FDA approvalMay 31, 2024 · 861d ago
- approvalONDANSETRON — FDA approvalJan 31, 2024 · 982d ago
- approvalONDANSETRON — FDA approvalJan 31, 2024 · 982d ago
- approvalONDANSETRON — FDA approvalMay 14, 2018 · 3070d ago
- approvalONDANSETRON — FDA approvalMar 7, 2018 · 3138d ago
🐶 often sniffed alongside
top 8- tagApproval382 co-mentions · 163 sources
- drugONDANSETRON250 co-mentions · 166 sources
- drugondansetron hydrochloride ODT250 co-mentions · 166 sources
- drugondansetron hydrochloride CR208 co-mentions · 124 sources
- drugONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE208 co-mentions · 124 sources
- drugONDANSETRON HYDROCHLORIDE208 co-mentions · 124 sources
- tagSmall Molecule92 co-mentions · 92 sources
- companyAurobindo Pharma Ltd29 co-mentions · 29 sources
comments(0)
5-min edit window · permanent after that